Overview

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the vascular effects of two commonly used diabetes medications, rosiglitazone and glyburide in type 2 diabetic patients.
Phase:
Phase 4
Details
Lead Sponsor:
St. Paul Heart Clinic
Collaborator:
GlaxoSmithKline
Treatments:
Glyburide
Rosiglitazone